Sharda Cropchem Limited, a leading global player in the generic crop protection chemicals sector, today announced its unaudited financial results for the quarter and half year ended September 30, 2025. The Company delivered a strong operational performance, driven by sustained volume momentum across key geographies, a robust product registration pipeline, and continued financial discipline.

During Q2 FY26, overall volumes grew 34.8 percent year-on-year, with agrochemical volumes expanding 36.1 per cent and non-agrochemical volumes rising 10.9 per cent. Revenue for the quarter increased 20 percent YoY to Rs 929 crore, supported by strong demand from NAFTA and European markets. The Company delivered significant margin improvement amid stabilizing raw material costs and favourable pricing dynamics, with gross margins expanding 690 basis points to 34.5 per cent. EBITDA grew 71 percent YoY to approximately Rs 139 crore, with margins rising 450 basis points to 15.0 per cent, positioning the business firmly on track to maintain healthy profitability in the 15–18 per cent range for FY26.

For H1 FY26, agrochemicals contributed 86 per cent of revenue and non-agrochemicals 14 per cent, with overall volumes up 23.7 per cent year-on-year. The Company continues to sustain strong return ratios, with ROCE at 21.6 per cent and ROE at 17.5 per cent as of September 30, 2025. Sharda remains debt-free with a solid liquidity position comprising Rs 794 crore of cash, bank balances and liquid investments. Capital expenditure during the period stood at Rs 250 crore, reflecting continued investments in strengthening the registration and regulatory infrastructure to drive long-term global expansion.

Ramprakash Bubna, Chairman & Managing Director, stated that the Company’s strategy of scale-led growth, operational resilience and tight cost control is delivering consistent results across value and volume parameters. He highlighted that NAFTA and Europe remain key growth engines and expressed confidence in maintaining strong margin performance as price dynamics improve further. He added that Sharda will continue to accelerate product registrations in FY26 with a planned capex outlay of Rs 450–500 crore, reinforcing the Company’s expanding market presence. As of September 30, 2025, registrations stood at 2,994, while 1,068 applications remain under review across multiple global markets, underscoring the Company’s commitment to widening access to high-quality, cost-effective crop protection solutions.

With its diversified product portfolio, global reach, debt-free balance sheet and proven regulatory capability, Sharda Cropchem enters the second half of FY26 with strong executional momentum and a clear roadmap to drive sustained growth and value creation for customers, partners and shareholders worldwide.